Insider Trading activities at Eyepoint Pharmaceuticals, Inc. (EYPT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyepoint Pharmaceuticals, Inc. (EYPT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eyepoint Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1314102.

Total stock buying since 2015: $130,818,517.
Total stock sales since 2015: $130,015,976.
Total stock option exercises since 2015: $3,205,411.


23 insiders reported insider trading activities at Eyepoint Pharmaceuticals, Inc. (EYPT):
Insider trading activities of Ross Leonard S
Insider trading activities of Jones David Scott
Insider trading activities of Zaderej Karen L.
Insider trading activities of Rogers Michael W
Insider trading activities of Ocumension Therapeutics
Insider trading activities of Lurker Nancy
Insider trading activities of Pine Michael Craig
Insider trading activities of Ashton Paul
Insider trading activities of Peterson Kristine
Insider trading activities of Liu Ye
Insider trading activities of Landis John B.
Insider trading activities of Paggiarino Dario A.
Insider trading activities of Dicicco Wendy F
Insider trading activities of Godshall Douglas Evan
Insider trading activities of Mazzo David J
Insider trading activities of Ando Goran
Insider trading activities of Essex Woodlands Ix, Llc
Insider trading activities of Barry James J
Insider trading activities of Duker Jay S.
Insider trading activities of Adamis Anthony P
Insider trading activities of Elston George
Insider trading activities of Guyer David R
Insider trading activities of Cormorant Global Healthcare Master Fund, Lp

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Eyepoint Pharmaceuticals, Inc. (EYPT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 10,000 $58,999 0 $0 248,992 $0
2024 2,310,005 $38,084,127 4,041,666 $79,378,111 502,281 $1,690,715
2023 2,507,292 $61,465,265 2,777,084 $49,558,582 174,400 $892,900
2022 1,000 $12,210 0 $0 57,401 $0
2021 0 $0 10,000 $201,480 45,564 $0
2020 128,000 $124,586 0 $0 453,141 $0
2019 100,500 $173,369 0 $0 237,898 $144,849
2018 25,470,390 $30,799,999 0 $0 407,058 $248,599
2017 56,700 $99,962 0 $0 0 $0
2016 0 $0 5,000 $23,500 15,000 $20,349
2015 0 $0 160,000 $854,303 160,000 $207,999

Table 2. Monthly summary of insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-07 0 $0 0 $0 29,778 $0
2025-05 10,000 $58,999 0 $0 7,500 $0
2025-02 0 $0 0 $0 32,834 $0
2025-01 0 $0 0 $0 178,880 $0
2024-08 23,240 $184,499 0 $0 0 $0
2024-07 0 $0 11,625 $116,994 39,552 $33,039
2024-06 0 $0 0 $0 2,000 $0
2024-05 850,000 $10,225,500 11,625 $147,044 9,775 $33,039
2024-04 581,765 $10,623,028 0 $0 0 $0
2024-03 0 $0 0 $0 50,404 $0
2024-02 0 $0 209 $5,954 81,277 $2,397
2024-01 855,000 $17,051,100 4,018,207 $79,108,119 319,273 $1,622,240
2023-12 2,507,292 $61,465,265 2,097,083 $41,129,382 77,083 $892,900
2023-08 0 $0 680,000 $8,429,194 0 $0
2023-07 0 $0 0 $0 2,000 $0
2023-06 0 $0 0 $0 2,000 $0
2023-05 0 $0 1 $6 0 $0
2023-02 0 $0 0 $0 93,317 $0
2022-11 0 $0 0 $0 15,258 $0
2022-03 1,000 $12,210 0 $0 0 $0
2022-02 0 $0 0 $0 42,143 $0
2021-11 0 $0 10,000 $201,480 0 $0
2021-06 0 $0 0 $0 1,420 $0
2021-02 0 $0 0 $0 44,144 $0

Table 3. Detailed insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-07-11 Zaderej Karen L. Option Ex 2,000 .00 0
2025-07-10 Duker Jay S. (President and CEO) Option Ex 16,667 .00 0
2025-07-10 Lurker Nancy Option Ex 11,111 .00 0
2025-05-25 Elston George (Chief Financial Officer) Option Ex 7,500 .00 0
2025-05-19 Zaderej Karen L. Buy 5,000 5.99 29,950
2025-05-16 Zaderej Karen L. Buy 5,000 5.81 29,049
2025-02-09 Duker Jay S. (President and CEO) Option Ex 7,000 .00 0
2025-02-09 Lurker Nancy Option Ex 20,000 .00 0
2025-02-09 Elston George (Chief Financial Officer) Option Ex 5,834 .00 0
2025-01-06 Duker Jay S. (President and CEO) Option Ex 20,794 .00 0
2025-01-06 Lurker Nancy Option Ex 75,134 .00 0
2025-01-06 Elston George (Chief Financial Officer) Option Ex 15,285 .00 0
2025-01-05 Duker Jay S. (President and CEO) Option Ex 30,000 .00 0
2025-01-05 Landis John B. Option Ex 10,000 .00 0
2025-01-05 Lurker Nancy Option Ex 12,667 .00 0
2025-01-05 Elston George (Chief Financial Officer) Option Ex 15,000 .00 0
2024-08-21 Ando Goran Buy 5,000 7.95 39,750
2024-08-20 Dicicco Wendy F Buy 2,567 7.79 19,996
2024-08-19 Zaderej Karen L. Buy 12,500 7.98 99,750
2024-08-16 Lurker Nancy Buy 3,173 7.88 25,003
2024-07-12 Guyer David R Sale 11,625 10.06 116,994
2024-07-12 Guyer David R Option Ex 9,775 3.38 33,039
2024-07-11 Zaderej Karen L. Option Ex 2,000 .00 0
2024-07-10 Duker Jay S. (President and CEO) Option Ex 16,666 .00 0
2024-07-10 Lurker Nancy (Executive Vice Chair) Option Ex 11,111 .00 0
2024-06-23 Adamis Anthony P Option Ex 2,000 .00 0
2024-05-14 Guyer David R Sale 11,625 12.65 147,044
2024-05-14 Guyer David R Option Ex 9,775 3.38 33,039
2024-05-06 Cormorant Global Healthcare Master Fund, Lp Buy 850,000 12.03 10,225,500
2024-04-18 Cormorant Global Healthcare Master Fund, Lp Buy 581,765 18.26 10,623,028
2024-03-30 Paggiarino Dario A. (Chief Medical Officer) Option Ex 50,404 .00 0
2024-02-09 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 9,967 .00 0
2024-02-09 Duker Jay S. (President and CEO) Option Ex 11,967 .00 0
2024-02-09 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,800 .00 0
2024-02-09 Lurker Nancy (Executive Vice Chair) Option Ex 37,534 .00 0
2024-02-09 Elston George (Chief Financial Officer) Option Ex 10,800 .00 0
2024-02-02 Jones David Scott (SVP & Chief Commercial Officer) Sale 209 28.49 5,954
2024-02-02 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 209 11.47 2,397
2024-01-26 Jones David Scott (SVP & Chief Commercial Officer) Sale 26,017 25.36 659,791
2024-01-26 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 26,017 8.08 210,217
2024-01-26 Paggiarino Dario A. (Chief Medical Officer) Sale 49,325 25.53 1,259,217
2024-01-26 Paggiarino Dario A. (Chief Medical Officer) Option Ex 49,325 13.05 643,839
2024-01-25 Jones David Scott (SVP & Chief Commercial Officer) Sale 600 25.00 15,000
2024-01-25 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 600 8.08 4,848
2024-01-25 Paggiarino Dario A. (Chief Medical Officer) Sale 600 25.00 15,000
2024-01-25 Paggiarino Dario A. (Chief Medical Officer) Option Ex 600 13.02 7,809
2024-01-24 Jones David Scott (SVP & Chief Commercial Officer) Sale 11,300 25.01 282,624
2024-01-24 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 11,300 8.08 91,304
2024-01-24 Paggiarino Dario A. (Chief Medical Officer) Sale 11,251 25.01 281,410
2024-01-24 Paggiarino Dario A. (Chief Medical Officer) Option Ex 11,251 13.02 146,431
2024-01-24 Lurker Nancy (Executive Vice Chair) Sale 29,956 24.98 748,240
2024-01-23 Jones David Scott (SVP & Chief Commercial Officer) Sale 900 25.00 22,500
2024-01-23 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 900 8.08 7,272
2024-01-23 Paggiarino Dario A. (Chief Medical Officer) Sale 5,135 25.00 128,375
2024-01-23 Paggiarino Dario A. (Chief Medical Officer) Option Ex 5,135 13.02 66,832
2024-01-23 Lurker Nancy (Executive Vice Chair) Sale 5,044 24.97 125,948
2024-01-22 Jones David Scott (SVP & Chief Commercial Officer) Sale 34,166 22.46 767,436
2024-01-22 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 34,166 10.80 368,992
2024-01-11 Liu Ye Sale 1,910,500 19.45 37,159,225
2024-01-11 Ocumension Therapeutics (Director) Sale 1,910,500 19.45 37,159,225
2024-01-11 Cormorant Global Healthcare Master Fund, Lp Buy 750,000 19.75 14,812,500
2024-01-09 Cormorant Global Healthcare Master Fund, Lp Buy 105,000 21.32 2,238,600
2024-01-08 Paggiarino Dario A. (Chief Medical Officer) Sale 22,913 21.13 484,128
2024-01-08 Paggiarino Dario A. (Chief Medical Officer) Option Ex 22,913 3.26 74,696
2024-01-06 Pine Michael Craig (Chief Corp Dev.&Strat. Officer) Option Ex 15,285 .00 0
2024-01-06 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 15,285 .00 0
2024-01-06 Duker Jay S. (President and CEO) Option Ex 20,793 .00 0
2024-01-06 Paggiarino Dario A. (Chief Medical Officer) Option Ex 15,285 .00 0
2024-01-06 Lurker Nancy (Executive Vice Chair) Option Ex 75,133 .00 0
2024-01-06 Elston George (Chief Financial Officer) Option Ex 15,285 .00 0
2023-12-13 Paggiarino Dario A. (Chief Medical Officer) Sale 1,458 20.00 29,160
2023-12-13 Paggiarino Dario A. (Chief Medical Officer) Option Ex 1,458 10.13 14,769
2023-12-08 Cormorant Global Healthcare Master Fund, Lp Buy 588,235 17.00 9,999,995
2023-12-06 Liu Ye Sale 266,242 18.41 4,901,515
2023-12-06 Ocumension Therapeutics (Director) Sale 266,242 18.41 4,901,515
2023-12-05 Liu Ye Sale 733,758 19.91 14,609,121
2023-12-05 Ocumension Therapeutics (Director) Sale 733,758 19.91 14,609,121
2023-12-04 Pine Michael Craig (Chief Corp Dev.&Strat. Officer) Sale 45,000 22.00 990,000
2023-12-04 Pine Michael Craig (Chief Corp Dev.&Strat. Officer) Option Ex 45,000 12.62 567,900
2023-12-04 Cormorant Global Healthcare Master Fund, Lp Buy 1,919,057 26.82 51,465,270
2023-12-04 Paggiarino Dario A. (Chief Medical Officer) Sale 30,625 22.00 673,750
2023-12-04 Paggiarino Dario A. (Chief Medical Officer) Option Ex 30,625 10.13 310,231
2023-12-04 Lurker Nancy (Executive Vice Chair) Sale 20,000 20.76 415,200
2023-08-31 Essex Woodlands Ix, Llc (10% Owner) Sale 78,495 10.59 831,576
2023-08-30 Essex Woodlands Ix, Llc (10% Owner) Sale 60,976 11.14 679,333
2023-08-29 Essex Woodlands Ix, Llc (10% Owner) Sale 87,854 11.15 979,659
2023-08-28 Essex Woodlands Ix, Llc (10% Owner) Sale 60,858 11.71 712,647
2023-08-25 Essex Woodlands Ix, Llc Sale 84,656 10.93 925,120
2023-08-24 Essex Woodlands Ix, Llc Sale 139,280 14.62 2,036,134
2023-08-23 Essex Woodlands Ix, Llc (10% Owner) Sale 121,103 13.05 1,580,878
2023-08-22 Essex Woodlands Ix, Llc (10% Owner) Sale 46,778 14.62 683,847
2023-07-11 Zaderej Karen L. Option Ex 2,000 .00 0
2023-06-23 Adamis Anthony P Option Ex 2,000 .00 0
2023-05-30 Liu Ye Sale 1 6.00 6
2023-02-09 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 9,967 .00 0
2023-02-09 Duker Jay S. (President and COO) Option Ex 11,967 .00 0
2023-02-09 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,800 .00 0
2023-02-09 Landis John B. Option Ex 3,000 .00 0
2023-02-09 Lurker Nancy (CEO) Option Ex 37,533 .00 0
2023-02-09 Elston George (Chief Financial Officer) Option Ex 10,800 .00 0
2023-02-09 Guyer David R Option Ex 3,000 .00 0
2023-02-09 Dicicco Wendy F Option Ex 3,000 .00 0
2023-02-09 Ando Goran Option Ex 3,250 .00 0
2022-11-01 Duker Jay S. (Chief Operating Officer) Option Ex 15,258 .00 0
2022-03-14 Pine Michael Craig (Chief Corp Dev.&Strat. Officer) Buy 1,000 12.21 12,210
2022-02-28 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 4,105 .00 0
2022-02-28 Paggiarino Dario A. (Chief Medical Officer) Option Ex 4,105 .00 0
2022-02-28 Lurker Nancy (President & CEO) Option Ex 12,466 .00 0
2022-02-21 Lurker Nancy (President & CEO) Option Ex 13,717 .00 0
2022-02-09 Landis John B. Option Ex 2,500 .00 0
2022-02-09 Dicicco Wendy F Option Ex 2,500 .00 0
2022-02-09 Ando Goran Option Ex 2,750 .00 0
2021-11-15 Lurker Nancy (President & CEO) Sale 10,000 20.15 201,480
2021-06-14 Paggiarino Dario A. (Chief Medical Officer) Option Ex 1,420 .00 0
2021-02-28 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 4,105 .00 0
2021-02-28 Paggiarino Dario A. (Chief Medical Officer) Option Ex 4,105 .00 0
2021-02-28 Landis John B. Option Ex 1,900 .00 0
2021-02-28 Lurker Nancy (President & CEO) Option Ex 12,467 .00 0
2021-02-28 Godshall Douglas Evan Option Ex 1,900 .00 0
2021-02-28 Guyer David R Option Ex 1,900 .00 0
2021-02-28 Dicicco Wendy F Option Ex 1,900 .00 0
2021-02-28 Ando Goran Option Ex 2,150 .00 0
2021-02-21 Lurker Nancy (President & CEO) Option Ex 13,717 .00 0
2020-09-04 Elston George (Chief Financial Officer) Buy 10,000 .48 4,800
2020-08-24 Elston George (Chief Financial Officer) Buy 10,000 .61 6,110
2020-06-30 Jones David Scott (SVP & Chief Commercial Officer) Option Ex 41,050 .00 0
2020-06-30 Paggiarino Dario A. (Chief Medical Officer) Option Ex 41,050 .00 0
2020-06-30 Lurker Nancy (President & CEO) Option Ex 124,667 .00 0
2020-06-27 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,000 .00 0
2020-06-27 Lurker Nancy (President & CEO) Option Ex 40,000 .00 0
2020-06-14 Paggiarino Dario A. (Chief Medical Officer) Option Ex 14,200 .00 0
2020-06-14 Lurker Nancy (President & CEO) Option Ex 45,000 .00 0
2020-03-12 Elston George (Chief Financial Officer) Buy 10,000 .96 9,600
2020-03-10 Lurker Nancy (President & CEO) Buy 98,000 1.06 104,076
2020-02-21 Lurker Nancy (President & CEO) Option Ex 137,174 .00 0
2019-11-15 Elston George (Chief Financial Officer) Buy 10,000 1.43 14,290
2019-10-09 Mazzo David J Option Ex 33,333 1.95 64,999
2019-09-06 Mazzo David J Option Ex 417 .00 0
2019-06-27 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,000 .00 0
2019-06-27 Ross Leonard S (See Remarks) Option Ex 6,667 .00 0
2019-06-27 Lurker Nancy (President & CEO) Option Ex 40,000 .00 0
2019-06-21 Duker Jay S. Option Ex 6,667 .00 0
2019-06-21 Peterson Kristine Option Ex 6,667 .00 0
2019-06-21 Godshall Douglas Evan Option Ex 6,667 .00 0
2019-06-21 Mazzo David J Option Ex 8,333 .00 0
2019-06-21 Rogers Michael W Option Ex 6,667 .00 0
2019-06-14 Paggiarino Dario A. (Chief Medical Officer) Option Ex 14,200 .00 0
2019-06-14 Ross Leonard S (See Remarks) Option Ex 8,280 .00 0
2019-06-14 Lurker Nancy (President & CEO) Option Ex 45,000 .00 0
2019-05-13 Landis John B. Buy 40,000 1.74 69,600
2019-04-12 Duker Jay S. Option Ex 20,000 1.77 35,400
2019-04-01 Duker Jay S. Buy 5,000 1.89 9,450
2019-04-01 Ross Leonard S (See Remarks) Option Ex 5,000 1.81 9,050
2019-03-29 Lurker Nancy (President & CEO) Buy 28,500 1.76 50,245
2019-03-29 Godshall Douglas Evan Buy 17,000 1.75 29,784
2019-03-29 Mazzo David J Option Ex 20,000 1.77 35,400
2018-12-22 Ross Leonard S (See Remarks) Option Ex 62,892 .00 0
2018-11-15 Rogers Michael W (Director) Option Ex 100,000 1.13 112,999
2018-06-27 Duker Jay S. (Director) Option Ex 12,500 .00 0
2018-06-27 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,000 .00 0
2018-06-27 Ross Leonard S (See Remarks) Option Ex 6,666 .00 0
2018-06-27 Lurker Nancy (President & CEO) Option Ex 40,000 .00 0
2018-06-27 Godshall Douglas Evan (Director) Option Ex 12,500 .00 0
2018-06-27 Mazzo David J (Director) Option Ex 17,500 .00 0
2018-06-27 Rogers Michael W (Director) Option Ex 12,500 .00 0
2018-06-25 Essex Woodlands Ix, Llc (10% Owner) Buy 16,864,066 1.26 21,333,043
2018-05-07 Barry James J (Director) Option Ex 12,500 .00 0
2018-04-20 Mazzo David J (Director) Option Ex 120,000 1.13 135,600
2018-03-28 Essex Woodlands Ix, Llc (10% Owner) Buy 8,606,324 1.10 9,466,956
2017-06-14 Lurker Nancy (President and CEO) Buy 56,700 1.76 99,962
2016-03-18 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2016-01-04 Ross Leonard S (Vice President, Finance) Sale 5,000 4.70 23,500
2016-01-04 Ross Leonard S (Vice President, Finance) Option Ex 5,000 1.81 9,050
2015-12-22 Ross Leonard S (Vice President, Finance) Sale 33,950 5.39 182,990
2015-12-22 Ross Leonard S (Vice President, Finance) Option Ex 33,950 1.81 61,449
2015-12-22 Ashton Paul (President & CEO) Sale 120,000 5.39 646,800
2015-12-22 Ashton Paul (President & CEO) Option Ex 120,000 1.13 135,600
2015-12-01 Ross Leonard S (Vice President, Finance) Sale 1,050 4.06 4,263
2015-12-01 Ross Leonard S (Vice President, Finance) Option Ex 1,050 1.81 1,900
2015-08-03 Ross Leonard S (Vice President, Finance) Sale 5,000 4.05 20,250
2015-08-03 Ross Leonard S (Vice President, Finance) Option Ex 5,000 1.81 9,050

Insider trading activities including stock purchases, stock sales, and option exercises of EYPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyepoint Pharmaceuticals, Inc. (symbol EYPT, CIK number 1314102) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.